Recent Press Releases

Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple Myelom

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Jan. 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and its subsidiary Onyx Pharmaceuticals, Inc., today announced the submission of a...

Roche delivers solid results in 2014

• Group sales up 5% at constant exchange rates , 1% in Swiss francs • Pharmaceuticals Division sales up 4%, driven by oncology (HER2-positive breast cancer medicines, Avastin) and strong...

Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results

Achieves Accelerated U.S. Regulatory Approval for Opdivo in Metastatic Melanoma Announces Early Stop of CheckMate -017, a Phase 3 Study of Opdivo, After Data Demonstrates Superior...

HealthWarehouse.com Responds to Senator Klobuchar & McCain On Reintroduction of Canadian Pharmacy Bill

HealthWarehouse.com Responds to Senator Klobuchar & McCain On Reintroduction of Canadian Pharmacy Bill

<0> HealthWarehouse.comLalit Dhadphale, 859-444-7341 </0>

Alimera Sciences' ILUVIEN® Receives Marketing Authorization in Finland and Luxembourg

ATLANTA, Jan. 26, 2015 /PRNewswire/ -- Alimera Sciences, Inc.

GSK expands its portfolio of medicines in the US for patients with asthma and COPD

Arnuity™ Ellipta® now available in the US for once-daily treatment of asthma.

World OTC Pharmaceuticals Market Forecast 2015-2025

LONDON, January 26, 2015 /PRNewswire/ --

Prospects for Leading Companies 

FDA approves first generic esomeprazole

The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults...

Research and Markets: Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis 2015

<0> Research and Markets: Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis 2015 </0>

Research and Markets: Global Diabetic Retinopathy Epidemiology and Patient Flow Analysis 2015

<0> Research and Markets: Global Diabetic Retinopathy Epidemiology and Patient Flow Analysis 2015 </0>

Research and Markets: Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis 2015

<0> Research and Markets: Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis 2015 </0>

Research and Markets: Global Allergic Rhinitis Epidemiology and Patient Flow Analysis 2015

<0> Research and Markets: Global Allergic Rhinitis Epidemiology and Patient Flow Analysis 2015 </0>

BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy

BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy

Actavis to Acquire Auden Mckenzie for 306M GBP

- Vaults Actavis to #1 Position in UK Generics - - Immediately Accretive to Non-GAAP Earnings - - Adds ~175 Marketed Products; Pipeline of ~40 Products - DUBLIN and LONDON, Jan. 26, 2015 /PRNewswire/...

FDA approves a second vaccine to prevent serogroup B meningococcal disease

FDA approves a second vaccine to prevent serogroup B meningococcal disease The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by...

Roche receives FDA clearance for next generation cobas MRSA/SA Test

New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide

PLEASANTON, Calif.,

Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA® (parathyroid hormone)

Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA® (parathyroid hormone) Dublin, Ireland – January 23, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) notes...

Novo Nordisk receives positive opinion from the European regulatory authorities for Saxenda® (liraglutide 3 mg) for the treatment of obesity (22 January 2015)

Bagsværd, Denmark, 22 January 2015 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted a positive...

Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter

FOR IMMEDIATE RELEASE — January 20, 2015 — LAKE FOREST, Ill., — Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall of one lot of 0.9% Sodium...

NICE recommends rivaroxaban (Xarelto) to prevent blood clots in people who have had a heart attack in final draft guidance

In final draft guidance published today NICE has confirmed its earlier positive draft decision recommending rivaroxaban (Xarelto, Bayer Healthcare), in combination with clopidogrel and aspirin, or...